Android app on Google Play

Oppenheimer Starts (SQNM), (GNOM), (CPHD) at Outperform, (MYGN), (AFFX), (GPRO), (PACB) at Perform

March 16, 2011 5:30 PM EDT Send to a Friend
Get Alerts SQNM Hot Sheet
Price: $3.74 -0.27%

Rating Summary:
    9 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 43 | Down: 33 | New: 14
Trade SQNM Now!
Join SI Premium – FREE
In the Medical Equipment and Supplies group this evening, an analyst at Oppenheimer has initiated coverage on a number of stocks:
  • Sequenom (Nasdaq: SQNM) with an Outperform rating and a $9 price target
  • Complete Genomics (Nasdaq: GNOM) with an Outperform rating and a $13 price target
  • Cepheid (Nasdaq: CPHD) with an Outperform rating and a $33 price target
  • Myriad Genetics (Nasdaq: MYGN) with a Perform rating and a $22 price target
  • Affymetrix (Nasdaq: AFFX) with a Perform rating
  • Gen-Probe (Nasdaq: GPRO) with a Perform rating and a $71 price target
  • Pacific Biosciences (Nasdaq: PACB) with a Perform rating and a $15 price target
Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.




You May Also Be Interested In


Related Categories

New Coverage

Add Your Comment